QUOTE AND NEWS
SeekingAlpha  Jun 27  Comment 
ByQuoth the Raven: I don't really want to harangue Amarin (AMRN) too much. The company and its shareholders have gone through enough since the company's FDA approval of Vascepa years ago. The company, after failing in its appeal for approval of...
SeekingAlpha  Jun 12  Comment 
By Big Alpha Research: In my previous article, I wrote about the risks and returns associated with investing in Amarin Corp. (AMRN), and concluded that the company should have enough cash to fund its operations and the research and development...
SeekingAlpha  Jun 12  Comment 
Amarin Corporation PLC (AMRN) Goldman Sachs 2014 Global Healthcare Conference June 11, 2014 6:20 p.m. ET Executives Gary Nachman – Goldman Sachs John Thero – Amarin Corporation PLC President and CEO Analysts ...
SeekingAlpha  Jun 5  Comment 
Amarin Corporation PLC (AMRN) Jefferies 2014 Global Healthcare Conference June 5, 2014 08:00 AM ET Executives John Thero - President and CEO Analysts Thomas Wei - Jefferies Presentation Thomas Wei -...
TheStreet.com  May 15  Comment 
NEW YORK (TheStreet) -- Amarin shares are falling, down 8.5% to $1.39 on Thursday, following the announcement that the company, along its wholly owned subsidiary, Corsicanto Limited, have entered into an senior note exchange agreement with...
StreetInsider.com  May 12  Comment 
UPGRADES Nimble Storage (NYSE: NMBL) upgraded by two today: Needham & Company from Buy to Strong Buy while moving its price target from $62 down to $35. Click Here for more color; and William Blair from Market Perform to Outperform. Click...
StreetInsider.com  May 12  Comment 
TESARO, Inc. (Nasdaq: TSRO) 19% HIGHER; announced positive top-line results from the third and final Phase 3 trial of rolapitant, an investigational neurokinin-1 (NK-1) receptor antagonist in development for the prevention of...
SeekingAlpha  May 9  Comment 
Amarin (AMRN) Q1 2014 Earnings Call May 09, 2014 8:00 am ET Executives Michael James Farrell - Principal Financial Officer, Principal Accounting Officer and Controller John F. Thero - Chief Executive Officer, President, Assistant...
Forbes  May 7  Comment 
Amarin is expected to book a narrower loss than a year ago when it reports first-quarter earnings on Friday, May 9, 2014. Analysts are expecting a loss of 18 cents per share, up from a loss of 44 cents per share a year ago.Over the past three...
The Hindu Business Line  May 4  Comment 
Dublin-based Amarin Pharma has filed a patent infringement case against Dr. Reddy’s Laboratories alleging that the latter is attempting to come out with generic versions of its patented drug Vascep...





 



References

This is a test No its not

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki